Skip to main content

Advertisement

SpringerLink
Log in

Pneumatosis Intestinalis Associated with the Tyrosine Kinase Inhibitor Nintedanib

  • LUNG IMAGES
  • Published:
Lung Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Raghu G, Rochwerg B, Zhang Y et al (2015) An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med 192(2):e3–e19

    Article  PubMed  Google Scholar 

  2. Richeldi L, Du bois RM, Raghu G et al (2014) Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. New Engl J Med 370(22):2071–2082

    Article  PubMed  Google Scholar 

  3. Coriat R, Ropert S, Mir O et al (2011) Pneumatosis intestinalis associated with treatment of cancer patients with the vascular growth factor receptor tyrosine kinase inhibitors sorafenib and sunitinib. Invest New Drugs 29(5):1090–1093

    Article  CAS  PubMed  Google Scholar 

  4. Lee JY, Han HS, Lim SN et al (2012) Pneumatosis intestinalis and portal venous gas secondary to gefitinib therapy for lung adenocarcinoma. BMC Cancer 12:87

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Vijayakanthan N, Dhamanaskar K, Stewart L et al (2012) A review of pneumatosis intestinalis in the setting of systemic cancer treatments, including tyrosine kinase inhibitors. Can Assoc Radiol J 63(4):312–317

    Article  PubMed  Google Scholar 

  6. Heng Y, Schuffler MD, Haggitt RC, Rohrmann CA (1995) Pneumatosis intestinalis: a review. Am J Gastroenterol 90(10):1747–1758

    CAS  PubMed  Google Scholar 

  7. Cabrera GE, Scopelitis E, Cuellar ML, Silveira LH, Mena H, Espinoza LR (1994) Pneumatosis cystoides intestinalis in systemic lupus erythematosus with intestinal vasculitis: treatment with high dose prednisone. Clin Rheumatol 13(2):312–316

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Icahn School of Medicine at Mount Sinai, Division of Pulmonary, Critical Care & Sleep Medicine, New York, NY, 10029, USA

    Armeen Poor & Sidney S. Braman

Authors
  1. Armeen Poor
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sidney S. Braman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sidney S. Braman.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Poor, A., Braman, S.S. Pneumatosis Intestinalis Associated with the Tyrosine Kinase Inhibitor Nintedanib. Lung 196, 373–375 (2018). https://doi.org/10.1007/s00408-018-0118-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-018-0118-6

Keywords

Search

Navigation